| Taylor Clark, OTD | |
|
1732 S 72nd St W, Billings, MT 59106-3538 | |
| (406) 651-2847 | |
| Not Available |
| Full Name | Taylor Clark |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1732 S 72nd St W, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528714128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTP-OT-LIC-8676 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Clark, OTD 4522 March Madness Way Unit 3, Billings, MT 59106-2843 Ph: (505) 401-4729 | Taylor Clark, OTD 1732 S 72nd St W, Billings, MT 59106-3538 Ph: (406) 651-2847 |
News Archive
Impax Laboratories, Inc. today reported adjusted net revenue in the third quarter of 2010, excluding the effect of a change in accounting for revenue received under the Company's Strategic Alliance Agreement with Teva, increased $42.6 million to $107.6 million compared to the prior year period, driven by sales of generic Adderall XR for which there were no sales in the third quarter of 2009, as well as increased sales of the Company's fenofibrate products.
A study from the Family Acceptance Project has found that lesbian, gay, bisexual, and transgender young people who experience sexual orientation change efforts during adolescence report attempts to change their sexual orientation both by their parents and by therapists and religious leaders.
Minnesota budget officials estimate it could cost the state as much as $40 million to run its health insurance exchange in 2015. The state-based online insurance marketplaces are a cornerstone of the federal health care overhaul.
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a Phase I clinical trial of its self-applied ViaDerm-Calcitonin product for the treatment of musculoskeletal disorders such as osteoarthritis and musculoskeletal pain.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
› Verified 6 days ago
Billings Clinic Occupational Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
John Philip Nordeck Iv, OTD Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1035 Yale Ave, Billings, MT 59102 Phone: 720-933-9258 | |
Carissa Seibold, MS,OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3940 Rimrock Rd, Billings, MT 59102 Phone: 406-655-5770 Fax: 406-655-5639 | |
Mrs. Diane Shirley Morledge Ham, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2520 17th St W, Suite 103, Billings, MT 59102 Phone: 406-294-1994 Fax: 406-294-1996 | |
Mrs. Dana Marie Foley, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Paula Pasek, OTR/CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 | |
Tessa C Gibbins, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Suite 10w, Billings, MT 59101 Phone: 406-238-6400 |